Inhibrx Biosciences, Inc. INBX Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Liquidity | ||||||
| Current ratio | 6.5×+2.5× | 3.9×-0.6× | 4.5×-0.5× | 5×-0.1× | 5.1×+1.2× | |
| Per Share | ||||||
| Book value per share | -$1.35-362% | $0.52-78.3% | $2.38-46.3% | $4.43-27.4% | $6.11-31.5% | |
| Valuation | ||||||
| Market capitalization | $1.4B+546% | $1.15B+136% | $487.87M+128% | $213.66M+5.5% | $202.52M-9.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Inhibrx Biosciences, Inc.'s ratios come from?
- Every ratio is computed from Inhibrx Biosciences, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
